Reviparin-sodium prevents complement-mediated myocardial injury in the isolated rabbit heart

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 5, 1997, Pages 658-666

  Park, J L ^a   Tanhehco, E J ^a   Kilgore, K S ^a   Gralinski, M R ^a   Lucchesi, B R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Complement; Membrane attack complex; Reviparin sodium

Indexed keywords

COMPLEMENT; COMPLEMENT MEMBRANE ATTACK COMPLEX; REVIPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE INJURY; HEART PROTECTION; HEMOLYSIS; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT; REGIONAL PERFUSION;

ANIMALS; ANTICOAGULANTS; CARDIOMYOPATHIES; COMPLEMENT ACTIVATION; COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY; COMPLEMENT C3B; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATINE KINASE; FIBRINOLYTIC AGENTS; HEART; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; PEPTIDE FRAGMENTS; RABBITS;

EID: 0030784613     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199711000-00017     Document Type: Article

References (25)